PE20020547A1 - Uso de la tolterodina en tratamientos del asma - Google Patents
Uso de la tolterodina en tratamientos del asmaInfo
- Publication number
- PE20020547A1 PE20020547A1 PE2001001035A PE2001001035A PE20020547A1 PE 20020547 A1 PE20020547 A1 PE 20020547A1 PE 2001001035 A PE2001001035 A PE 2001001035A PE 2001001035 A PE2001001035 A PE 2001001035A PE 20020547 A1 PE20020547 A1 PE 20020547A1
- Authority
- PE
- Peru
- Prior art keywords
- tolterodine
- phenylproyl
- asthma treatments
- asthma
- treatments
- Prior art date
Links
- 208000006673 asthma Diseases 0.000 title abstract 2
- OOGJQPCLVADCPB-HXUWFJFHSA-N tolterodine Chemical compound C1([C@@H](CCN(C(C)C)C(C)C)C=2C(=CC=C(C)C=2)O)=CC=CC=C1 OOGJQPCLVADCPB-HXUWFJFHSA-N 0.000 title abstract 2
- 229960004045 tolterodine Drugs 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- BDIAUFOIMFAIPU-UHFFFAOYSA-N valepotriate Natural products CC(C)CC(=O)OC1C=C(C(=COC2OC(=O)CC(C)C)COC(C)=O)C2C11CO1 BDIAUFOIMFAIPU-UHFFFAOYSA-N 0.000 title abstract 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940043279 diisopropylamine Drugs 0.000 abstract 1
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Substances CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 abstract 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical class C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24289900P | 2000-10-24 | 2000-10-24 | |
| US28312001P | 2001-04-11 | 2001-04-11 | |
| US31421801P | 2001-08-22 | 2001-08-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20020547A1 true PE20020547A1 (es) | 2002-06-12 |
Family
ID=27399612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2001001035A PE20020547A1 (es) | 2000-10-24 | 2001-10-18 | Uso de la tolterodina en tratamientos del asma |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6538035B2 (fr) |
| EP (1) | EP1330241A2 (fr) |
| JP (1) | JP2004513099A (fr) |
| AR (1) | AR031032A1 (fr) |
| AU (1) | AU2002212962A1 (fr) |
| CA (1) | CA2422901A1 (fr) |
| MX (1) | MXPA03003592A (fr) |
| PE (1) | PE20020547A1 (fr) |
| WO (1) | WO2002034245A2 (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9203318D0 (sv) * | 1992-11-06 | 1992-11-06 | Kabi Pharmacia Ab | Novel 3,3-diphenylpropylamines, their use and preparation |
| US6890920B2 (en) * | 2001-10-26 | 2005-05-10 | Pharmacia & Upjohn Company | Quaternary ammonium compounds |
| WO2003039464A2 (fr) * | 2001-11-05 | 2003-05-15 | Pharmacia & Upjohn Company | Aerosol antimuscarinique |
| PL372395A1 (en) * | 2002-02-19 | 2005-07-25 | Pharmacia Corporation | Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence |
| US7005449B2 (en) | 2002-04-23 | 2006-02-28 | Pharmacia & Upjohn Company | Tolterodine salts |
| MXPA05011059A (es) * | 2003-04-15 | 2005-12-12 | Pharmacia & Upjohn Co Llc | Compuestos de amonio cuaternario y su uso como agentes antimuscarinicos. |
| EP1620083A2 (fr) * | 2003-04-18 | 2006-02-01 | Pharmacia & Upjohn Company LLC | Polytherapies |
| US7629358B2 (en) * | 2004-03-17 | 2009-12-08 | Pfizer Inc | Compounds useful for the treatment of diseases |
| ES2268987B1 (es) | 2005-08-05 | 2008-02-01 | Ragactives, S.L. | Procedimiento para la obtencion de 3,3-difenilpropilaminas. |
| CA2643097C (fr) | 2006-03-20 | 2012-03-13 | Pfizer Limited | Derives amine |
| WO2009019599A2 (fr) | 2007-08-08 | 2009-02-12 | Themis Laboratories Private Limited | Compositions à libération prolongée comprenant de la toltérodine |
| WO2009034432A2 (fr) * | 2007-09-14 | 2009-03-19 | Pfizer Limited | Nouveaux composés actifs utilisés comme antagonistes des récepteurs muscariniques |
| KR101188333B1 (ko) | 2008-02-20 | 2012-10-09 | 에스케이케미칼주식회사 | 안정성이 우수하고 경피제로 유용한 톨테로딘 결정성산부가염 |
| CN110372571B (zh) | 2018-04-12 | 2022-11-15 | 中国科学院大连化学物理研究所 | 一种2-(2,2-二芳基乙基)-环胺衍生物或盐及合成和应用与组合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5382600A (en) | 1988-01-22 | 1995-01-17 | Pharmacia Aktiebolag | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
| SE9203318D0 (sv) | 1992-11-06 | 1992-11-06 | Kabi Pharmacia Ab | Novel 3,3-diphenylpropylamines, their use and preparation |
| US6124354A (en) | 1996-07-29 | 2000-09-26 | Pharmacia & Upjohn Ab | Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation |
| KR20000057548A (ko) | 1996-12-13 | 2000-09-25 | 알프레드 엘. 미첼슨 | 광학적 전송물질 및 결합재 |
-
2001
- 2001-10-18 PE PE2001001035A patent/PE20020547A1/es not_active Application Discontinuation
- 2001-10-22 AR ARP010104944A patent/AR031032A1/es unknown
- 2001-10-23 CA CA002422901A patent/CA2422901A1/fr not_active Abandoned
- 2001-10-23 AU AU2002212962A patent/AU2002212962A1/en not_active Abandoned
- 2001-10-23 EP EP01981309A patent/EP1330241A2/fr not_active Withdrawn
- 2001-10-23 MX MXPA03003592A patent/MXPA03003592A/es unknown
- 2001-10-23 US US10/045,135 patent/US6538035B2/en not_active Expired - Fee Related
- 2001-10-23 JP JP2002537299A patent/JP2004513099A/ja active Pending
- 2001-10-23 WO PCT/US2001/027779 patent/WO2002034245A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AR031032A1 (es) | 2003-09-03 |
| AU2002212962A1 (en) | 2002-05-06 |
| CA2422901A1 (fr) | 2002-05-02 |
| MXPA03003592A (es) | 2003-06-19 |
| US6538035B2 (en) | 2003-03-25 |
| US20020161054A1 (en) | 2002-10-31 |
| WO2002034245A2 (fr) | 2002-05-02 |
| JP2004513099A (ja) | 2004-04-30 |
| EP1330241A2 (fr) | 2003-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20020547A1 (es) | Uso de la tolterodina en tratamientos del asma | |
| ES2235311T8 (es) | Formulación de budesónida/formoterol para inhalación que tiene una densidad aparente de vertido de 0,30 a 0,36 g/ml, un proceso para preparar la formulación y el uso de la misma. | |
| ECSP034732A (es) | Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias | |
| AR041969A1 (es) | Medicamento para el tratamiento de la enfermedad pulmonar obstructiva cronica | |
| AR082825A2 (es) | Inhibidores heterociclicos nitrogenados de mek, composiciones farmaceuticas que los contienen, metodos para prepararlos y uso de los mismos para el tratamiento de trastornos hiperproliferativos o inflamatorios | |
| LTPA2014019I1 (lt) | Fenetanolamino dariniai, skirti kvėpavimo ligoms gydyti | |
| BR0111206A (pt) | Derivados de arilmetilamina para uso como inibidores de triptase | |
| NO20054839L (no) | Formulering for en oppmalt-dose inhalator ved anvendelse av hydro-fluor-alkaner som drivmidler | |
| ES2178943B1 (es) | Uso de compuestos organicos en el tratamiento de enfermedad pulmonar obstructiva cronica. | |
| ECSP045081A (es) | Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados | |
| IS7814A (is) | Fenetanólamín afleiða í meðhöndlun á öndunarfærasjúkdómum. | |
| EA200200551A1 (ru) | Новые содержащие тиотропий порошки для ингаляции | |
| ECSP044992A (es) | Inhibidores de la alquín-aril fosfodiesterasa-4 | |
| CL2008000762A1 (es) | Compuestos derivados de pirimidinas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la psoriasis, diabetes, artritis reumatoide, entre otras enfermedades ( divisional solicitud 1147-02). | |
| MXPA03010134A (es) | Derivados de ciclohexan-1-4-diamina sustituidos. | |
| CR7583A (es) | Nueva sal formiato de o-desmetil venlafaxina | |
| ATE484551T1 (de) | Oberflächenmodifizierte siliciumdioxid- titandioxid-mischoxide | |
| BR0213358A (pt) | Uso de flibanserina | |
| CL2007001752A1 (es) | Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral. | |
| CR9626A (es) | Formas de dosificacion de liberacion retardada oral altamente biodisponible de un o-desmetilvenlafaxin succinato | |
| AR039633A2 (es) | Uso de un compuesto tipo cabergolina para preparar un medicamento para el tratamiento de la fibromialgia y el sindrome de fatiga cronica | |
| BRPI0508700A (pt) | uso de sns-595, composição farmacêutica, e, pó liofilizado | |
| ECSP045493A (es) | Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a | |
| CL2007002380A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica. | |
| CL2007003643A1 (es) | Composicion farmaceutica de azimilidina que comprende 0,5% a aproximadamente 2,5% (w/w) de agua; y uso para el tratamiento de arritmias cardiacas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |